Clinical Trial Update: ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. [Phase 1]

View source ↗

Summary

A Phase 1b trial (ARTEMIS-103) evaluates HS-20093 in patients with bone and soft tissue sarcoma, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Osteosarcoma, Soft Tissue Sarcoma (STS) | Phase 1 | Status: NOT_YET_RECRUITING